Growth In The Number of Surgeries Among Animals Are Responsible For Driving Veterinary Surgical Instruments

The increasing demand for veterinary surgical instruments is driven by the rising companion animal population coupled with the growing demand for pet insurance, the rising animal health awareness levels along with the increasing animal healthcare expenditure. In addition, the growth in the number of veterinary practitioners and the growth in the number of soft tissue injuries and trauma surgeries among pets are responsible for driving the overall growth of this market.

The global veterinary surgical instruments market is estimated to reach USD 1,029.0 Million by 2021 from USD 748.4 Million in 2016, grow at a CAGR of 6.6% during the forecast period.

Download PDF Brochure Here: http://bit.ly/2f7q6CL

Key Players:

The market players, namely, B. Braun Vet Care GmbH (Germany), Medtronic Plc. (Ireland), Ethicon Inc. (U.S.), and JORGEN KRUSSE A/S (Denmark) held the major share of the Veterinary Surgical Instruments Market  and will continue to dominate the market between 2016 and 2021.

Market Geography:

The global Veterinary Surgical Instruments Market  is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, North America commanded a major share of the market. However, Asia-Pacific is expected to witness the highest growth rate during the forecast period.

About Report :

Based on product type, the market is segmented into sutures, staplers and accessories, handheld devices, electro-surgery instruments, and others. The handheld devices are further segmented into forceps, scalpels, surgical scissors, hooks & retractors, and trocars & cannulas. 

Based on animal type, the market is segmented into small animals and large animals. The small animals segment is further segmented into canines, felines, and other small animals, while the large animals segment is further segmented into equines and other large animals.

To Know More : http://bit.ly/2wYwa7r

Growth Of Dialysis Market In Emerging Nations ..!!

The rising prevalence of end-stage renal disease (ESRD), diabetes, and hypertension is stimulating the demand for dialysis treatment in the emerging nations. Furthermore, low preference of patients for kidney transplantation, technological advancements, and substantial government healthcare expenditure on the treatment of ESRD are adding to the growth prospects of dialysis products and services market in the emerging nations.

Get PDF Brochure Here : http://bit.ly/2wg2Vgs

Key players :

The major players in the Dialysis market in emerging nationsinclude Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (U.S.), B. Braun Melsungen AG (Germany), Nipro Corporation (Japan), and Nikkiso Co. Ltd. (Japan). On the basis of region, the Dialysis market in emerging nations is segmented into India, Asia (excluding India), and the MENA region.

 Market Geography:

The market in Asia is expected to grow at a higher rate during the forecast period (2015-2020). This high growth is predominantly driven by the growing number of Dialysis centers, low preference for kidney transplantation, rising awareness about renal diseases, development of low-cost products, and increasing focus of Dialysis firms on the Asian market. 

About Report :

The Dialysis market in emerging nations is categorized into two broad segments, namely, Hemodialysis and peritoneal Dialysis. The Hemodialysis market is segmented into products and services. Hemodialysis products include Hemodialysis machines and Hemodialysis consumables/supplies, whereas Hemodialysis services are classified into in-center services and home services. The peritoneal Dialysis market, segmented into products and services, includes peritoneal Dialysis machines, concentrates/dialysates, catheters, transfer sets, and other consumables such as tubing sets, drain bags, disconnect caps, bag connections, catheter stabilizing devices, and ports.

To Know More : http://bit.ly/2uOr11J

Global Fertility Testing Devices Market Is Poised To Grow At A CAGR Of 7.5% During The Forecast Period To Reach USD 216.8 Million By 2020

Major Factor For The Growth of Fertility Testing Devices Market :
The emergence of advanced and easy-to-use ovulation monitors with high accuracy, rising median age of first-time pregnancies in women, and increasing awareness about fertility testing are driving the growth of the market. In addition, factors such as declining fertility rate among women across the globe and easy availability of ovulation monitors on e-commerce websites are further stimulating the growth of the market.

Download PDF  Brochure: http://bit.ly/2hZdK0c

The global Fertility Testing Devices  market is poised to grow at a CAGR of 7.5% during the forecast period and expected to reach a value of USD 216.8 Million by 2020.

Market Geography :

Fertility Testing Devices  market is divided into North America (comprising the U.S. and Canada), Europe (comprising Germany, U.K., France, and the Rest of Europe), Asia-Pacific, and the Rest of the World.

Key Players :

Fertility Testing Devices  market include SPD Swiss Precision Diagnostics GmbH (Switzerland), Church & Dwight Co., Inc. (U.S.), Prestige Brands Holdings, Inc. (U.S.), Fairhaven Health, LLC (U.S.), HiLin Life Products, Inc. (U.S.), Fertility Focus Limited (U.K.), and Geratherm Medical AG (Germany).

About Report :

The global Fertility Testing Devices  market is broadly categorized into two segments, namely, ovulation prediction kits and fertility monitors. The ovulation prediction kits segment accounts for the larger share of the global market, while the fertility monitors segment is expected to grow at the higher CAGR in the forecast period.

The high growth of this segment is driven by the high accuracy of fertility monitors, especially in women suffering from PCOS, and increase in the number of product launches of advanced fertility monitors. The fertility monitors segment includes saliva-based monitors, urine-based monitors, and others.

To Know More: Click Here

Current scenario and the future growth prospects of the “Cardiovascular Ultrasound System”

Major Factor Driving The Market Growth :

Increasing incidence of cardiovascular diseases, technological advancements, and advantages of echocardiography over invasive cardiac diagnostic procedures are the major drivers for the Cardiovascular Ultrasound System Market . However, insufficient reimbursement scenario and economic impact of adopting new technologies are restraining the growth of the market.

Download PDF Brochure: http://bit.ly/2eV9fiK

The Cardiovascular Ultrasound System Market is projected to reach USD 1.66 Billion by 2021 from USD 1.27 Billion in 2016, growing at a CAGR of 5.4% during the forecast period (2016–2021)

Key players :

Key players in the Cardiovascular Ultrasound System Market  include GE Healthcare (U.S.), Philips healthcare (The Netherlands), Siemens Healthcare (Germany), Hitachi Medical Corporation (Japan), and Toshiba Medical Systems Corporation (Japan).

About Report :

The Cardiovascular Ultrasound System Market  is broadly segmented into test type, technology, device display, end user, and region. Based on test type, the market is categorized into transthoracic echocardiogram, stress echocardiogram, transesophageal echocardiogram, and fetal & intracardiac echocardiogram. The stress echocardiogram segment is expected to account for the largest share of the market in 2016. This is due to the major advantage of the stress echocardiogram that it can provide data of the cardiac muscles and valves before and after the stress of the heart muscle.

On the basis of technology, the Cardiovascular Ultrasound System Market  is segmented into 2D, 3D & 4D, and Doppler imaging. The 2D technology is estimated to account for the largest share of the market in 2016, whereas the 3D & 4D technology segment is estimated to grow at the highest CAGR during the forecast period.

To Know More : http://bit.ly/2wZOVW1

FDA and Ce Mark Approvals Driving the Adoption of Surgical Sealants and Adhesives

Major Factor Which Are Driving The Growth Of Surgical Sealants and Adhesives Market :

Increasing incidence of chronic diseases along with the rapid growth in the geriatric population, increasing need manage blood loss in patients, and growing number of surgical procedures performed are the major factors driving the growth of the surgical sealants and adhesives market

                                                           

Get PDF Brochure Here : http://bit.ly/2hMM8eA

On the basis of product, the market is segmented into natural/biological sealants and adhesives and synthetic & semi-synthetic sealants and adhesives. The natural/biological sealants and adhesives segment is further categorized into type and origin.

On the basis of type, the natural/biological sealants segment have been divided into polypeptide/protein-based and polysaccharide-based sealants and adhesives. The polypeptide/protein-based sealants segment is further categorized into fibrin, gelatin, collagen, and albumin-based adhesives, while the polysaccharide-based sealants segment comprise of chitosan-based and other polysaccharide-based adhesives.

 On the basis of origin, the natural/biological sealants and adhesives segment is categorized into human blood-based and animal-based. The synthetic and semi-synthetic sealants and adhesives segment is divided into cyanoacrylates, polyethylene glycol hydrogels, urethane-based adhesives, and other synthetic adhesives.

On the basis of application, the global surgical sealants and adhesives market is segmented into CNS, general, cardiovascular, orthopedic, cosmetic, urological, pulmonary, ophthalmic surgeries, and other applications.

To Know More : http://bit.ly/2fuaGZi

High Incidence Chronic Diseases Driving Viral Inactivation Testing Market

The global viral inactivation market was valued at USD 320.5 Million in 2016 and poised to grow at a CAGR of 12.3% between 2016 and 2021, to reach USD 573.0 Million in 2021

Download PDF Brochure Here: http://bit.ly/2y3dnoK

The Major Drivers For  Viral Inactivation Market :

Rapid growth in pharmaceutical and biotechnology industries and strong trend of R&D investments in life sciences industry. Increasing number of new drug launches, rise in chronic disease burden, and increasing government support for the pharmaceutical and biotechnology industries will also aid the growth of this market.

Target Audience for this Report:

• Viral inactivation product manufacturers and vendors
• Research associations related to pharmaceutical and biotechnological research
• contract research organizations (CROs)
• Various research and consulting firms
• Healthcare institutions
• Research institutes
• Distributors of viral inactivation equipment

Key Players :

Major players in the viral inactivation market include Clean Cells (France), Charles River Laboratories International, Inc. (U.S.), Danaher Corporation (U.S.), Merck KGaA (Germany), Parker Hannifin (U.S.), Rad Source Technologies (U.S.), Sartorius AG (Germany), SGS S.A. (Switzerland), Texcell, Inc. (France), Viral Inactivated Plasma Systems SA (Switzerland), and WuXi PharmaTech (Cayman) Inc. (China).

About Report :

The application segments included in this report are blood & blood products, cellular & gene therapy products, stem cell products, tissue & tissue products, and vaccines and therapeutics. Of these the vaccines and therapeutics application hold the highest share.The product segments included in the report are kits and reagents, services, and viral inactivation systems and accessories.

To Know More : http://bit.ly/2jtcOBY

Adoption of Disposable Medical Sensors in Diagnostic Applications Across The World Owing To Their Varied Benefits

Factors Of Disposable Medical Device Sensors Market Growth :

Growing prevalence of diabetes and other infectious diseases across the globe, government support for research and development activities in medical sensors, various benefits such as faster analysis, low costs, ease of use, and rising needs to curtail escalating healthcare costs.

The Disposable Medical Device Sensors   market is poised to reach USD 5,936 Million by 2020, growing at a CAGR of 10.3% during the forecast period of 2015 to 2020.

Get PDF Brochure Here: http://bit.ly/2ybQEaz

Key Players:

Some of the major players in this market include Medtronic plc. (Ireland), GE Healthcare (U.K.), Philips N.V. (Netherlands), Smiths Medical (U.K.), TE Connectivity (Switzerland), Freescale Semiconductors, Inc. (U.S.), Omnivision Technologies, Inc. (U.S.), STMicroelectronics (Switzerland), Analog Devices, Inc. (U.S.), and Honeywell International, Inc. (U.S.).

About Report:

The Disposable Medical Device Sensors   market is segmented into patient monitoring devices, diagnostic testing devices, imaging devices, and therapeutic devices. The diagnostic testing devices segment is further divided into HIV test kits, pregnancy test kits, drug and alcohol test kits, and blood glucose test strips.

The therapeutic devices segment is further divided into insulin pump sensors, dialysis device sensors, cardiac therapy devices, and cardiac catheter sensors. The patient monitoring devices segment is categorized into continuous blood pressure monitors, pulse oximeters, cardiac monitors, continuous glucose monitoring devices, implantable loop recorders, smart pills, and others. The imaging devices segment is divided into capsule endoscopes and disposable endoscopes.

To Know More : http://bit.ly/2x6dEJC

Enteral feeding is a growing requirement among the rising geriatric population..!!

The Major Factor Driving and Restraining Market Growth :

The global enteral feeding formulas market is mainly driven by the rising incidences of chronic diseases and disorders, rapidly growing geriatric population, increasing healthcare expenditure, rising prevalence of preterm births, and increasing demand for homecare.

However, factors such as complications associated with enteral nutrition, patient safety risks, and the occurrence of feeding and medication errors are expected to restrain the growth of the enteral feeding formulas market to a certain extent.

Get PDF Brochure Here: http://bit.ly/2uxJHBx

The global enteral feeding formulas market is projected to reach USD 5.95 Billion by 2020, at a CAGR of 7.6% from 2015 to 2020.

Key players :

Some of the prominent players in the global Enteral Feeding Formulas Market  are Abbott Laboratories (U.S.), Nestlé S.A. (Switzerland), Danone S.A. (France), Fresenius Kabi AG (Germany), Mead Johnson Nutrition Company (U.S.), B. Braun Melsungen AG (Germany), Hormel Foods, LLC (U.S.), Victus Inc. (U.S.), Meiji Holdings Co., Ltd. (Japan)

About Report :

On the basis of application, the market is segmented into oncology, gastroenterology, neurology, diabetes, critical care, and other applications. Other applications primarily include diseases and disorders of the heart, renal system, lungs, and liver, along with psychiatric disorders. The oncology application segment held the largest share of the Enteral Feeding Formulas Market  in 2015, primarily due to high prevalence of malnutrition among cancer patients.

To  Know More : http://bit.ly/2uuimAp

Advanced And Easy-To-Use Ovulation Monitor With High Accuracy ..!!

Major Factor For The Growth of Fertility Testing Devices Market :

The emergence of advanced and easy-to-use ovulation monitors with high accuracy, rising median age of first-time pregnancies in women, and increasing awareness about fertility testing are driving the growth of the market. In addition, factors such as declining fertility rate among women across the globe and easy availability of ovulation monitors on e-commerce websites are further stimulating the growth of the market. 

Download PDF  Brochure: http://bit.ly/2hZdK0c

The global Fertility Testing Devices  market is poised to grow at a CAGR of 7.5% during the forecast period and expected to reach a value of USD 216.8 Million by 2020.

Market Geography

Fertility Testing Devices  market is divided into North America (comprising the U.S. and Canada), Europe (comprising Germany, U.K., France, and the Rest of Europe), Asia-Pacific, and the Rest of the World.

Key Players

Fertility Testing Devices  market include SPD Swiss Precision Diagnostics GmbH (Switzerland), Church & Dwight Co., Inc. (U.S.), Prestige Brands Holdings, Inc. (U.S.), Fairhaven Health, LLC (U.S.), HiLin Life Products, Inc. (U.S.), Fertility Focus Limited (U.K.), and Geratherm Medical AG (Germany).

About Report

The global Fertility Testing Devices  market is broadly categorized into two segments, namely, ovulation prediction kits and fertility monitors. The ovulation prediction kits segment accounts for the larger share of the global market, while the fertility monitors segment is expected to grow at the higher CAGR in the forecast period. 

The high growth of this segment is driven by the high accuracy of fertility monitors, especially in women suffering from PCOS, and increase in the number of product launches of advanced fertility monitors. The fertility monitors segment includes saliva-based monitors, urine-based monitors, and others.

To Know More: http://bit.ly/2vUuaN0

Technological Advancements in Interventional Cardiology and Peripheral Vascular Devices

Factors such as the aging population, rising incidence of cardiovascular diseases, increasing demand of minimally invasive procedures, and technological advancements are expected to drive the growth of this market.The interventional cardiology market is expected to reach USD 31.47 Billion by 2021 from USD 21.83 Billion in 2016, at a CAGR of 7.1%.

Get PDF Brochure Here: http://bit.ly/2uDGzna

Key players :

The major players in the interventional cardiology market include Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), B. Braun Melsungen AG (Germany), Cordis Corporation (U.S.), C.R. Bard, Inc. (U.S.), Medtronic plc (U.S.), and Terumo Corporation (Japan).

About Report :

On the basis of type, the angioplasty stent market is segmented into drug-eluting stents, bare-metal stents, and bioabsorbable stents. On the basis of type, the catheters market is segmented into IVUS/OCT, angiography catheters, and guiding catheters. In 2016, the angiography catheters segment is expected to account for the largest share of the market.On the basis of type, the EVAR stent grafts market is segmented into abdominal aortic aneurysms and thoracic aortic aneurysms. In 2016, the abdominal aortic aneurysms segment is expected to account for the largest share primarily due to the rising incidence of smoking and hypertension.

Value Addition for the Buyer:

This report aims to provide insights into the global interventional cardiology & peripheral vascular devices market. It provides valuable information on interventional cardiology & peripheral vascular devices product segment and end user. Details on regional markets for these segments are also presented in this report. In addition, leading players in the market are profiled to understand the strategies undertaken by them to be competitive in this market.

To Know More About It: http://bit.ly/2uE8eog

Increasing Use of Synthesized Oligonucleotides in Molecular Diagnostics and Clinical Applications

The market is mainly driven by factors such as rising demand for synthesized oligonucleotides due to the growing field of molecular diagnostics, increasing government investments to develop genomic technologies, rising venture capital investments, increasing demand for synthetic genes, and increasing R&D expenditure in pharmaceutical and biotechnological companies.

Download PDF Brochure Here : http://bit.ly/2uBPHcp

The Oligonucleotide Synthesis Market  is expected to reach USD 2.20 Billion by 2021 from USD 1.33 Billion in 2016, at a CAGR of 10.6% from 2016 to 2021.

Key market players :

Agilent Technologies Inc. (U.S.), Bioautomation Corporation (U.S.), L.G.C Biosearch Technologies (U.S.), Eurofins Genomics (Germany), Eurogentec S.A (Belgium), GE Healthcare (U.S.), Integrated DNA Technologies (IDT) (U.S.), Nitto Denko Avecia Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Sigma-Aldrich Corporation (U.S.) (part of Merck KGaA (Germany)).

Market Geography :

The global market is dominated by North America, followed by Europe, Asia-Pacific, Latin America, Middle East and Africa. The market in Asia-Pacific is expected to grow at a highest CAGR during the forecast period. Factors such as the growing availability of synthesized oligos, along with an increase in R&D funding and activities in the APAC region contribute to the growth of this oligonucleotide synthesis in Asia-Pacific region. Furthermore, the increasing focus of prominent players on APAC is another factor driving the growth of this market.

About Market :

On the basis of application the Oligonucleotide Synthesis Market  is further segmented into research, diagnostic and therapeutics. Research segment is expected to account for the largest share of Oligonucleotide Synthesis Market  in 2016. Diagnostic segment is expected to grow at the highest CAGR during the forecast period.

The growth of this segment is mainly attributed to the emerging application of molecular diagnostics (MDx) and genetic testing. The increasing use of technologies such as DNA microarrays in the analysis of biological samples and developing molecular oncology diagnostics tests also contribute in the growth of molecular diagnostics market.

To Know More : http://bit.ly/2vASxeT

Global Trends of Computerized Physician Order Entry Market

CPOE is an electronic entry process utilized by medical practitioners to enter medication orders and other treatment related instructions particularly for hospitalized patients under care. It reduces errors related to handwriting as well as reduces the time taken for order completion. The order entry is transmitted over a network to various departments within a hospital, including pharmacy, laboratory, and radiology.  

The global computerized physician order entry (CPOE) market was valued at $999.9 Million in 2014,and Computerized Physician Order Entry Market worth 379 Million USD by 2019, and is projected to grow at a CAGR of 6.6% during the forecast period from 2014 to 2019.

Get PDF  Brochure Here :http://bit.ly/2uxzd5g

Key players :

The key players profiled in the global CPOE market are Allscripts (U.S.), Athenahealth, Inc. (U.S.), Siemens Healthcare (Germany), Philips Healthcare (Netherlands), Medical Information Technology, Inc. (U.S.), Cerner Corporation (U.S.), eClinicalWorks LLC (U.S.), Epic systems (U.S.), GE healthcare (U.K.), Mckesson Corporation (U.S.), and Carestream Health (U.S.). 

Market Geography :

The market, on the basis of region, has been classified into four regions, namely, North America, Europe, Asia-Pacific, and Rest of the World. North America held the largest share of 59.5% in the total global CPOE market, which was followed by Europe. The rising number of installations in North America is due to the high adoption of advanced technology, wherein a greater emphasis is laid on hospital automation.

About Report :

The global CPOE Market has been segmented on the basis of five categories, namely, type, component, deployment, end-user, and region. On the basis of type, the market is segmented into integrated CPOE and standalone CPOE, wherein the integrated CPOE sub-segment dominated the global CPOE market with a share of 75.0% in 2014.

On the basis of component, this market is further divided into services, software, and hardware, wherein the services sub-segment has the largest market value. On the basis of deployment, this market is segmented into web-based, on premise, and cloud based, wherein the web-based sub-segment has the largest market value. 

To Know More : http://bit.ly/2uxwIQc 

The Current As Well As Future Prospects Of Endoscopy Medical Devices..!!

Major Factors Driving :

Increasing investments, funds, and grants by government bodies worldwide; rising number of hospitals and growing hospital investments in endoscopy instruments; growing patient preference for minimally invasive surgeries; technological advancements; favorable reimbursement coverage in select countries; and the rising prevalence of diseases Furthermore, growing healthcare market in the emerging economies and increasing number of free-trade agreements are to serve as opportunities in this market.

The endoscopy equipment market is projected to reach USD 35.36 Billion by 2021, growing at a CAGR of 6.2% during the forecast period of 2016 to 2021.

 

Download PDF Brochure Here : http://bit.ly/2xM4RtW

                                                                            

Endoscopes and endoscopy equipment is extensively used in laparoscopy, gastrointestinal endoscopy, arthroscopy, obstetrics/gynecological endoscopy, urology endoscopy, bronchoscopy, mediastinoscopy, otoscopy, and laryngoscopy, among others. On the basis of product, the market is segmented into endoscopes, visualization systems, other endoscopy equipment, and accessories.

Market Geography :                                           

The market is categorized into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Asia-Pacific is expected to grow at the highest rate during the forecast period. The major factors driving the growth of this market include German-Asian partnerships, endoscopy research support in Japan, government investments and venture capital investments in China, and the increasing number of endoscopic surgeries & improving endoscopy infrastructure in India.

 

Japan, being one of the leading nations in terms of technology and technological development, is the homeland for top players of the endoscopy market and a mature medical equipment manufacturing industry. Olympus Corporation, Fujifilm Holdings Corporation, Welch Allyn, and Pentax Medical (Hoya Corporation), among others, are some top players of the endoscopy equipment market headquartered in Japan. Their domestic presence offers an array of opportunities to garner a stronger market share in the country. This can be attributed to their greater awareness of the market as compared to foreign players, easy accessibility to the market, and easy availability of products to end users.

China, being an emerging nation for endoscopy equipment, has seen many investments by venture capitalists for small and medium-sized companies. In May 2015, DiNovA (China) Venture Capital invested in Shanghai Outai Medical Equipment Co., Ltd (China), which manufactures bronchoscopes, laryngoscopes, gastrointestinal video endoscopes, colonoscopes, and light sources. Furthermore, the company invested in three deals in China, as of May 2015. The company has the largest local distribution network in China, with approximately 120 distributors and strong distribution capabilities in Jiangsu, Shanghai, Zhejiang, and Shandong. The continuous influx of venture capital for local players in China is expected to aid the production of innovative and new devices in the region, thus propelling the market during the forecast period.

The Asia-Pacific Conference, which takes place in every two years, provides German and Asian decision-makers in the business and political arenas with a platform for exchanging ideas about the latest economic issues. These meetings help in building the relationship between Germany and Asian countries. Additionally, a majority of Asian countries have free trade agreements (FTAs) with Germany, making business in this region more favorable. The Chinese government considers free trade agreements as a new platform for speeding up growth and strengthening its economy. As of October 2015, China has 19 FTAs under consideration, of which 14 have been signed and implemented. Partnerships and FTAs stimulate the flow of innovative and high-quality medical technology and pharmaceuticals from Germany to the Asian healthcare market.

The rising middle class population, growing purchasing power, and adoption of westernized lifestyles, leading to the rising incidence of conditions such as obesity and cardiovascular disease, have created a significant demand for hospitals with improved infrastructure in India. This has triggered government initiatives to increase the bed capacities of existing hospitals and establish new hospitals. According to the Indian 12th Five Year Plan (2012-2017), the bed capacity of hospitals in the country is expected to be increased by 650,000 beds by 2017. Additionally, public and private investments have been made to establish new hospitals or expand/renovate existing facilities.

To Know More : http://bit.ly/2vDV9JB